Ueda Toshihiko, Shimizu Hideyuki, Hashizume Kenichi, Koizumi Kiyoshi, Mori Mitsuharu, Shin Hankei, Yozu Ryohei
Section of Cardiovascular Surgery, School of Medicine, Keio University, Tokyo, Japan.
Ann Thorac Surg. 2003 Dec;76(6):1951-6. doi: 10.1016/s0003-4975(03)01136-6.
The early outcome after aortic arch surgery has improved. However, some operative survivors have died as a result of postoperative problems soon after discharge. This study determines the factors affecting mortality within 1 year of total arch replacement.
Between July 1993 and November 2001, 103 patients (mean age 65 +/- 11 years, 26 women, 35 dissections) underwent total arch replacement through a median sternotomy using a branched arch graft with selective cerebral perfusion. Eighteen operations including 14 acute dissections were performed on an emergency basis. Concomitant procedures were root replacement in 5 patients, mitral valve replacement in 1, coronary artery bypass in 14, and open endovascular stent-graft in 9. The average time (minutes) for bypass, aortic cross-clamp, selective cerebral perfusion, and distal arrest were respectively 273 +/- 79, 163 +/- 54, 145 +/- 36, and 69 +/- 22.
Mechanical heart support was necessary in 3 patients. Stroke occurred in 9 patients, transient neurologic dysfunction in 7, and paraplegia/paraparesis in 4. The only independent determinant for postoperative stroke was a history of stroke (odds ratio 16.3, 95% confidence interval: 2.8 to 93.8). Thirty-one patients required ventilator support for more than 5 days. Hemodialysis was needed in 5 patients. Sternal infection or mediastinitis occurred in 6 patients. The in-hospital mortality was 12% (12 of 103). The actuarial survival rate at 1 year was 83%, and was 67% at 5 years. For the 1-year mortality independent determinants were emergency surgery (odds ratio 5.3, 95% confidence interval: 1.6 to 17.9) and age 75 years or older (odds ratio 4.0, 95% confidence interval: 1.1 to 13.9).
Total arch replacement using a branched arch graft with selective antegrade cerebral perfusion has a favorable 1-year mortality rate except for patients undergoing emergency surgery and for elderly patients.
主动脉弓手术的早期预后已有所改善。然而,一些手术幸存者在出院后不久因术后问题死亡。本研究确定了影响全弓置换术后1年内死亡率的因素。
1993年7月至2001年11月期间,103例患者(平均年龄65±11岁,26例女性,35例夹层)通过正中胸骨切开术,使用带分支的弓部移植物并采用选择性脑灌注进行全弓置换。其中18例手术(包括14例急性夹层)为急诊手术。同期手术包括5例根部置换、1例二尖瓣置换、14例冠状动脉搭桥和9例开放式血管内支架植入。体外循环、主动脉阻断、选择性脑灌注和远端阻断的平均时间(分钟)分别为273±79、163±54、145±36和69±22。
3例患者需要机械心脏支持。9例发生卒中,7例出现短暂性神经功能障碍,4例出现截瘫/轻瘫。术后卒中的唯一独立决定因素是卒中病史(比值比16.3,95%置信区间:2.8至93.8)。31例患者需要呼吸机支持超过五天。5例患者需要血液透析。6例患者发生胸骨感染或纵隔炎。住院死亡率为12%(103例中的12例)。1年的精算生存率为83%,5年时为67%。1年死亡率的独立决定因素为急诊手术(比值比5.3,95%置信区间:1.6至17.9)和年龄75岁及以上(比值比4.0,95%置信区间:1.1至13.9)。
采用带分支的弓部移植物并进行选择性顺行性脑灌注的全弓置换术,除急诊手术患者和老年患者外,1年死亡率较低。